Company News

09/20/2022

Embody, Inc. Announces $10.4 Million Series C Funding Round

Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced that it closed a $10.4 million Series C funding round led by Genesis Innovation Group’s cultivate(MD) Capital Funds LP. The financing will enable Embody to expand its world-class operations, post-market clinical studies of the recently launched Tapestry RC System for rotator cuff

09/20/2022

Bonumose Announces Key Advisory and Leadership Appointments

Bonumose, Inc. – an enzyme technology company with solutions for sugar reduction and other globally critical industries – is pleased to announce the following appointments. Dr. Andrew Fordyce has accepted a key advisory role with Bonumose. Dr. Fordyce most recently was Executive Vice President and Food & Beverage Divisional Head for Novozymes, a global leader

09/15/2022

NEW BREAKTHROUGH TEST DETECTS AND PREDICTS SEVERITY OF COVID-19

CHARLOTTESVILLE, Va., /PRNewswire/ — AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in patients while also determining the best treatment options for each specific case. The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right

09/14/2022

Streck Announces Series B Investment in Ceres Nanosciences

La Vista, Nebraska – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment will be used to accelerate the development and commercialization of both diagnostic and research use products utilizing Ceres’ Nanotrap® technology platform.​ “Streck has a deep presence in and knowledge of the diagnostics industry and shares

09/09/2022

With the help of software, NoVa’s Jeeva wants to increase access to clinical trials

The Manassas, Virginia SaaS company is making it easier for remote patients to connect with clinical trial data. Virginia founder Harsha Rajasimha sees clinical trials as a crucial piece of the healthcare puzzle. But not everyone gets to take advantage of them. Before he launched a startup, Rajasimha was just an older brother who had

09/08/2022

Civica Inc. to Expand in Greater Richmond-Petersburg Region, Investing $27.8 Million for a New Testing Facility

Nonprofit generic drug company to create 51 new jobs at testing and R&D lab in Chesterfield County that will support Petersburg manufacturing operation RICHMOND, VA – Governor Glenn Youngkin today announced that non-profit Civica Inc. (Civica) will invest $27.8 million to establish a new laboratory testing facility at Meadowville Technology Park in Chesterfield County. The company